Class Analogy (SIMCA) shows that MNP (diagnosis based on negative symptoms) is better modeled with PHEM symptoms, FTD and PMR than with negative symptoms. In conclusion, in MNP, a restricted sample of the schizophrenia population, negative and PHEM symptoms, FTD and PMR belong to one underlying latent vector reflecting general psychopathology and, therefore, may be used as an overall severity of schizophrenia (OSOS) index. The bi-dimensional concept of positive and negative symptoms and type I and II schizophrenia is revised.
Introduction
Schizophrenia is characterized by various symptom domains the two most important being positive symptoms, including delusions, hallucinations, excitation, hostility, disorganized thinking, and negative symptoms, including affective flattening, avolition, alogia, anhedonia (Mellor, 1991; Marneros et al., 1991; Cuesta and Peralta, 1995) . Positive symptoms are considered to be new and maladaptive mental processes and behaviors that were not present before the onset of schizophrenia and that have emerged as signs of the disorder (Burton, 2012) . Negative symptoms, on the other hand, are conceptualized as emotions (hedonia), thought processes (logic thinking) and behaviors (social interactions) that the patient has lost as a consequence of the disorder (Burton, 2012) .
Based on this distinction between positive and negative symptoms of schizophrenia patients were subdivided according to a two-syndrome concept into those with mainly positive symptoms, named type I schizophrenia, and those with mainly negative symptoms, named type II schizophrenia (Crow, 1985) . When present during acute psychotic exacerbations and the interepisode more stable phases of illness the negative symptom cluster is referred to as deficit schizophrenia (Ahmed et al., 2015; Kirkpatrick et al., 1989 ). Previously, Bleuler described schizophrenia as a psycho-organic illness comprising two syndrome clusters, namely a primary cluster characterized by loosening of associations and withdrawal (negative symptoms) and accessory symptoms including some of the positive symptoms (Jablensky, 2010) . Kraepelin described schizophrenia as "dementia praecox" or an early type of "dementia" characterized by deterioration in neurocognitive functions and goal-directed behaviors, which are negative symptoms (Jablensky, 2010) . Nevertheless, it is debated whether negative symptoms increase in severity along a continuum from the healthy state to schizophrenia patients with a "fully developed 5 domains appear to be strongly related.
Furthermore, we delineated formal thought disorders (FTD) and psychomotor retardation (PMR) as two other major clinical domains that shape the phenemenology of schizophrenia and especially MNP (Sirivichayakul et al., 2019b; Maes et al., 2019a) . Firstly, FTD is characterized by aberrations in abstract and concrete thinking, including disorganized, illogical and inadequate thought processes coupled with intrusions, fluid thinking and loosened associations (Bleuler, 1950;  Simpson and Davis, 1985 ; Andreasen and Grove, 1986; Bachman and Cannon, 2012; Kircher et al., 2018) . We detected that FTD is, in fact, a clinical symptom of the memory deficit syndrome in schizophrenia and especially MNP and that FTD together with memory disorders explain a large part of the variance (around 92%) in negative and psychosis symptoms (Sirivichayakul et al., 2019b) . Secondly, PMR is another symptom domain characterized by impairments in gross and fine motor performance, slow motor responses and slow movements that define schizophrenia and especially MNP (Maes et al., 2019a ). In addition, PMR is strongly associated with other symptom domains including psychosis, hostility, excitation, mannerism, and negative (PHEMN) symptoms (Maes et al., 2019a) . Nevertheless, no research has examined whether the PHEMN symptom domains and FTD and PMR are intercorrelated in subjects with MNP, a restricted subsample of the schizophrenia population, and whether these symptoms may perhaps belong to one and the same underlying construct reflecting the severity of overall psychopathology.
Hence, this study was performed to examine whether these different symptom domains are interrelated phenomena in schizophrenia and whether those domains belong to an underlying latent vector reflecting general psychopathology.
Subjects and Methods

Participants
In this study, we included 120 patients with deficit schizophrenia or major neuro-cognitive psychosis (MNP) and 54 healthy subjects. Schizophrenia patients and healthy individuals were recruited from the same catchment area, i.e. Baghdad city, Iraq. Patients were recruited at the IbnRushd Training Hospital for Psychiatric Medicine, Baghdad, Iraq (December 2018 until February 2019). Controls were staff members or their family members or friends. All schizophrenia patients were in a stabilized phase of illness and did not suffer from acute episodes the year prior to the study. Patients were diagnosed according to DSM-IVTR criteria as "schizophrenia" and according to the Schedule of Deficit Schizophrenia (SDS) criteria as "deficit schizophrenia" (Kirkpatrick et al., 1989 ). Moreover, all schizophrenia patients also complied with the diagnostic criteria of MNP as published by Kanchanatawan et al. (2018b) . Since the MNP diagnostic criteria are somewhat more restrictive than those of deficit schizophrenia, it is more appropriate to use the label MNP although all patients also suffer from deficit schizophrenia. Therefore, we will employ the label MNP all over the text.
Exclusion criteria for patients and controls were: a) lifetime use of medications that interfere with immune functions including immunosuppressive drugs and glucocorticoids; b) use of supplements with ω3-polyunsaturated fatty acids or antioxidants the month prior to the study; c) neurodegenerative and neuroinflammatory disorders including Parkinson's disease, stroke, multiple sclerosis, and Alzheimer's disease; d) (auto)immune illnesses including rheumatoid arthritis, psoriasis, inflammatory bowel disease, COPD and diabetes mellitus (type 1). Controls were excluded when they presented a current or lifetime diagnosis of DSM-IV-TR axis I diagnosis and additionally when they showed a family history of schizophrenia or psychosis. Schizophrenia patients were excluded when they suffered psychotic episodes the year prior to the study or axis-1 8 (MMSE) (Folstein et al., 1975 ) in a validated Arabic translation. We also assessed the drug state of the patients; 68 were treated with fluphenazine, 108 with risperidone and 11 with olanzapine.
The diagnosis of tobacco use disorder (TUD) was made using the DSM-IV-TR criteria. Body mass index (BMI) was assessed the same day as the clinical interview and was scored as body weight (kg) / length (m 2 ). We constructed different z-unit weighted composite scores based on items of the BPRS, HDRS, PANSS, SANS and HAM-D as published previously (Maes et al., 2019a;
Sirivichayakul et al., 2019a; 2019b). Table 1 shows the different z unit-weighted composite scores used in the current study to assess the severity of symptom domains including PHEMN (psychosis, hostility, excitation, mannerism, negative) symptoms, and FTD, and PMR.
Statistics
One-way analysis of variance was used to assess differences in scale variables between groups, and analysis of contingency tables (χ 2 tests) was used to assess associations between categorical variables. Correlations between scale variables were assessed using Pearson's product moment correlation or Spearman's rank order correlation coefficients or partial correlation coefficients (while adjusting for extraneous variables). We used multivariate GLM analysis to examine the effects of explanatory variables (age, sex, education, drug state) on the 8 symptom domains, while tests for between-subject effects were used to examine the effects of significant explanatory variables on each of the symptom domains. These multiple tests were checked for false discovery rate (FDR) using the (Benjamini-Hochberg procedure,1995).
Multiple regression analysis was used to examine the significant biomarkers that predict the symptom domains using an automatic stepwise method (p-to-entry of 0.05 and p-to-remove 0.06) while checking the R 2 change. In addition, the analysis was checked for collinearity (using VIF and tolerance) and homoscedasticity (using the White and Breusch-Pagan tests). When the latter was rejected, we used heteroscedasticy-consistent standard error (SE) (HCSE) or robust SE estimates using the HC3 method. Moreover, analyses were bootstrapped (n=2000) and the bootstrapped results are reported when there are differences between both approaches.
Single joint PCA performed on the 8 symptom domains in MNP and controls was used to visualize the distribution of both groups in a 2D space (the PC plot) whereby MNP patients and controls are differentiated by marker colors and shapes (Unscrambler, CAMO, 2019). We employed a standard deviation weighting process and a 20-fold cross-validation scheme, while outlier limits are based on 0.05% F-residuals and Hotelling's T2. Correlation loadings for each of symptom domains are displayed in a plot that comprises two ellipses, the outer ellipse indicating 100% explained variance and the inner one explaining 50% explained variance.
We used exploratory factor analysis (EFA) as a data-driven method to explore the factor structure of schizophrenia phenomenology in patients with MNP and all subjects combined (MNP and controls). EFA was performed using FACTOR, windows version 10.5.03 (Ferrando, 2013 (Ferrando, , 2017 ) to examine the factor structure of the dataset. Factors were extracted using the robust unweighted least squares (RULS) method and the number of bootstrap samples was 500 (Ferrando and Soft independent modeling of class analogy (SIMCA) is a supervised machine learning method which builds separate PCA models for all classes, thus one model for MNP and another model for controls (CAMO, 2018) . A training set (comprising 50% of the MNP subjects and 50%
of the controls) is used to construct the PCA models and a test (validation) set (the remaining 50%)
is used to validate the models. The number of PCs used to build the models in the training set is determined by cross-validation after outliers are deleted as detected by sample residual vs samples and Hotelling's T2 vs samples plots. Subjects from the test set are then classified into the group for which they display the best similarity based on critical limits for two relevant distances, namely Si, that is the subject to model distance (reflecting how far the subject is located from the target class) and Hi that is the leverage of one subject to the model center (reflecting how different the subject is from the other subjects). The test subjects are consequently projected into both PCA models whereby SIMCA allocates cases to the models by comparing the computed distances to the model subspaces at alpha=0.05. As such, subjects may be assigned to the target model (MNP class members) or the control model (alternative class members) or they can be allocated to both models (hybrids) or to none of the models (outsiders). Healthy controls that intrude into the MNP target class are identified as "aliens". In this study we used a) the model- Results. Associations between negative and other symptoms Table 3 shows the results of correlation analyses (partial correlations after adjusting for sex, age and education) between negative symptoms (SANS and PANSSnegative) and PHEM symptoms, FTD and PMR. In the combined study group as well as in MNP, there were significant associations (all at the p<0.001 level after p correction for false discovery rate, FDR) between SANS/PANSSnegative and all PHEM symptoms and FTD and PMR. We have also examined whether the drug state of the patients had any significant effects on these associations using partial correlations adjusted for use of olanzapine, risperidone or fluphenazine. However, we found that the correlation coefficients reported in Table 3 did not change after adjusting for the drug state.
Socio-demographic data
Based on these results we examined the association between negative symptoms (here we show only the results obtained with PANSSnegative values) and PHEM symptoms, FTD and PMR while allowing for the intervening effects of extraneous variables (age, sex, education and drug state of the patients). Table 4 , regression #1 shows that, in all subjects combined, 90.8% of the variance in PANSSnegative scores was explained by the regression on psychosis, hostility, education, and female sex. Psychosis had by far the greatest impact and other symptoms domains were not significant. Figure 1 shows the partial regression plot between PANSSnegative and psychosis in all subjects combined (thus independent from education, sex and hostility). Table 4 , regression #2 shows that, in MNP, 71.0% of the variance in PANSSnegative scores was explained by the regression on psychosis, hostility and female sex. Psychosis had again the greatest impact, while other symptoms domains and education were not significant. Figure 2 shows the partial regression plot between PANSSnegative and psychosis in MNP. We have also examined (in MNP)
the association between PANSSpositive subscore and PHEM, FTD and PMR symptoms allowing for the effects of age, sex and education. Table 4 , regression #3 shows that 94.0% of the variance in positive symptoms was explained by the regression on psychosis, excitation, hostility, FTD and age (all positively associated). Psychosis and excitation had the most impact on the PANSSpositive score.
PCA and exploratory factor analysis
In order to visualize the distribution of the subjects in a 2D space we performed PCA on both controls and MNP patients and extracted PCs from the data set comprising SANS, PANSSnegative, PHEM symptoms, FTD and PMR. Figure 3 shows a PC score plot, namely PC1
(explaining 87% of the variance) vs PC2 (explaining 4%), which displays the distribution of MNP patients (red dots) and controls (blue squares) in the 2D space made by both PCs. MNP patients cluster at the right-hand side of the PC plot, whereas healthy controls cluster at the left-hand side and there is no overlap between the two classes with a large boundary (street) between both classes. Figure 4 shows the correlation loadings of the 8 symptom domains on PC1 vs PC2. All variables are located between both ellipses and additionally group close together suggesting that they all contribute to the separation of both classes and are significantly and positively intercorrelated. showed that the advised number of factors was one. Table 5 shows that all 8 variables loaded highly Table 5 shows also the results of EFA in the combined groups and shows that the data should be regarded as essentially unidimensional and that all parameters (factor scores, explained variance, model fit indices, H-index, FDI) were even more adequate as compared with the factor model in MNP patients. As such, EFA showed that the data structure of the 8 clinical domains is essentially unidimensional. In order to exclude potential common method bias, we have used the correlation matrix procedure (Tehseen et al., 2017) . The association matrix between the different latent constructs showed no large associations (all r<0.90), indicating lack of common method bias.
SmartPLS
First we tested the reflective -reflective HCM described in the statistics section. This PLS analysis was performed in subjects with MNP with age and MMSE (single indicators) predicting the main higher order construct (HOC) named "overall severity of schizophrenia" (OSOS) LV performed the same analyses in all subjects combined. Table 6 shows that all symptom domains loaded highly on the LV and that this LV has excellent internal consistency reliability and convergent validity. In the total study group, CTA supports a reflective model, while blindfolding shows a construct cross-validated communality of Q 2 =0.774, indicating a very good predictive relevance.
SIMCA
Using the 8 symptom domains as input variables to build PCA models we did not find any indication of outliers in the control and MNP PCA models and therefore no subjects were omitted from the models. MNP was modeled using 6 PCs, while controls were modeled using 3 PCs. All input variables showed significant modeling power in both classes (all > 0.7404) while also the discriminant power was significant, in decreasing order of power: hostility (352. Figure 5 shows the Si/S0 vs Hi plot and the distances of all subjects allocated to the test set to the critical limits of the control class, as well as their leverage to the same class. All MNP and control subjects were correctly authenticated as belonging to their target class while no aliens could be detected (e.g. MNP subjects intruding the critical limits of the control class). In addition, no outsiders were detected and also the classification table showed that all cases were correctly classified yielding an accuracy of 100%.
We performed a second SIMCA whereby the MNP class (training set) was modeled with hostility, PMR, excitation, mannerism, and psychosis and projected the test set into this SIMCA model. We found that 57 MNP patients were correctly authenticated as belonging to the MNP class while 3 cases fell outside the critical limits, one with an increased distance to the model and 2 who showed increased leverage. Since no outsiders were detected and no aliens (controls intruding the MNP class) the sensitivity of these symptom domains for MNP was 95% and specificity 100%. We performed a third SIMCA analysis whereby the SANS negative symptom subdomains (flattening, alogia, apathy, anhedonia, and attention) were used to model MNP. Projecting the subjects of the test set into the target class showed that 51 MNP cases were authenticated as belonging to the target class while 8 cases showed an increased distance to the MNP model and one an increased leverage. Since there were no aliens (controls intruding the MNP class), the sensitivity is 85% with a specificity of 100%.
Discussion
The first major finding of this study is that a single latent trait, which is essentially unidimensional, underlies the key symptom domains of schizophrenia, namely SANS and PANSS negative, PHEM symptoms, FTD and PMR. These findings extend those of a previous report showing that in a study sample of Thai schizophrenia patients and controls the same symptom domains may be conceptualized under an overall single trait (Maes et al., 2019a; Sirivichayakul et al., 2019b). Nevertheless, in the current study, performed on Iraq patients, we used a restricted study sample of patients with MNP or deficit schizophrenia, indicating that even in a restricted study sample the same latent trait could be established. In fact, restricted sample variance artificially weakens existing correlations and generalizability, and therefore, the correlation coefficients obtained in an unrestricted sample should be corrected for range restriction (Wiberg and Sundstrom, 2009; Lakes, 2013 ). An unrestricted sample should comprise MNP and SNP patients as well as normal controls to estimate their actual inter-correlations. Therefore, we have also computed the associations and factor loadings in the combined group of controls and MNP patients and found, as expected, quite similar albeit somewhat higher correlation coefficients and factor loadings.
The second major finding of this study is that the latent construct extracted from the eight domains showed excellent psychometric properties. Firstly, the obtained AVE value (0.682) showed that the model converged to an adequate result and, therefore, has good convergent validity. Secondly, the high Cronbach alpha and rho values (both > 0.9) indicate good internal consistency reliability or composite reliability. Thirdly, other statistics showed an adequate construct cross-validated communality indicating good predictive relevance and construct replicability. Fourth, the latent construct has also good concurrent validity as established by a highly significant association with a more general index of psychopathology. As such, this single trait underpinning the eight domains represents a reliable and replicable reflective score that indicates overall severity of schizophrenia (OSOS).
Our findings that one OSOS factor represents all eight domains contrasts with previous theories which consistently used a two-dimensional approach of schizophrenia phenomenology. Bleuler's concept of "schizophrenia" conceptualized that a distinction between basic (or negative) symptoms, and additional (positive) symptoms is the hallmark of schizophrenia (Jablensky, 2010).
Crow also made a quite similar two-dimensional concept that distinguishes between positive and negative symptoms (Crow, 1985) . The results of the present study showed that the latent phenomenon OSOS is reflectively measured through eight effect indicators. As a consequence, this reflective construct is the common cause of the manifestations (eight domains) and the latter is to a large extent modulated by the OSOS index. In addition, we examined second-order constructs (Hierarchical Component Models)
with the repeated indicator method and observed that the lack of discriminant validity between PHEM and negative domains did not allow to build a well-fitted Hierarchical Component Model.
In the current study and in the study of Sirivichayakul et al. (2019a) we found that the negative domain indicators could reliably be added to the positive or PHEM latent traits. Moreover, here we detected that the psychosis domain could reliably be added to the negative latent vector.
Moreover, there are some issues with the commonly applied practice to assess positive symptoms using rating scales. In this respect, the current study showed that a large part of the variance in the PANSS positive subscale score could be explained by the combined effects of three "positive"
areas (psychosis, hostility, excitation) and FTD, suggesting that "positive symptoms" should be The third major finding of this study is that MNP or deficit schizophrenia is, as a diagnostic category, better modeled (predicted) by PHEM symptoms, FTD, and PMR than by negative symptoms. A combination of all eight domains provided an accuracy of 100% while the top-5 discriminatory predictors were in descending order: hostility, PMR, excitation, and mannerism followed at a distance by the negative SANS symptoms. Previously, we detected, in another study sample, that both negative and PHEM symptoms discriminate MNP or deficit schizophrenia from SNP or non-deficit schizophrenia with great accuracy (Kanchanatwan et al., 2018a; 2018b). These findings are at odds with Crow's theory and with the conclusion of Roy and Devriendt (1994) that "it appears to be more productive to conceive negative symptoms as distinct dimensions rather than distinct diseases". Firstly, in the current study, we have shown that negative symptoms are not distinct dimensions, and secondly, MNP or deficit schizophrenia is a distinct nosological entity (Kanchanatwan et al., 2018a; 2018b) albeit it is better modeled by the PHEM, PMR and FTD symptom domains than by negative symptoms.
At first sight, it may be difficult to reconcile our findings that MNP (deficit schizophrenia) is a distinct nosological entity (categorical distinction) based on negative and PHEM domains and that the dimensional OSOS index (a continuum based on the same symptoms) underpins schizophrenia phenomenology. Nevertheless, not only symptom domains but also neuro-immune and cognitive features model discriminate MNP from SNP and controls (Kanchanatwan et al., 2018a; 2018b). As such, stable-phase schizophrenia comprises two qualitatively distinct nosological classes whereby MNP is the full-blown phenotype and SNP is a less-well-developed phenotype, while the symptom areas are intertwined and shape MNP (deficit schizophrenia) as a qualitatively distinct class.
The current study should be interpreted with regard to its possible limitations. Firstly, this study was performed in patients with stable phase schizophrenia and, therefore, cannot be generalized to acute episodes of the illness. Future research should examine the associations among different symptom domains in acute episodes of schizophrenia. Secondly, this is a case-control study and thus no causal inferences can be made. Future research should examine the time-relationships between the different symptom domains from the premorbid stage to later stages. Thirdly, studies examining the association among clinical variables are prone to common method bias (CMB) although using the correlation matrix procedure no evidence for any CMB could be detected.
In conclusion: negative symptoms (SANS and PANSS negative subscale score), psychosis, hostility, excitation, mannerism, FTD and PMR should be treated as essentially unidimensional.
The latent vector extracted from those eight symptoms domains showed excellent convergent validity, internal consistency reliability, composite reliability, predictive relevance, construct replicability and concurrent validity. The latent trait underpinning the eight domains is reflectively measured through 8 symptom domains and represents a reliable and replicable index of overall severity of schizophrenia (OSOS). The concept "positive symptoms" cannot be validated and positive symptoms should be dissected into relevant domains, namely psychosis, hostility, and excitation, while also other areas are important including PMR, FTD, and mannerism. The bidimensional concepts of positive and negative symptoms and type I and II (and deficit) schizophrenia should be revised.
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All the contributing authors have participated in preparation of the manuscript . This plot shows the distances of all subjects allocated to the test set to the critical limits of the control class (blue squares) as well as their leverage to the same class. All healthy control subjects were correctly authenticated as belonging to the control target class while no patients with major neuro-cognitive psychosis or deficit schizophrenia intruded into the critical limits of the control class. All patients showed very large distances and leverages toward the class model and centre, respectively. Table 1 . Indices of the different symptom domains and biomarker composite scores used in the current study Symptom domains Z unit weighted composite symptom scores Psychosis sum of z score of item 1 on the positive subscale of the PANSS (zPANNSP1, delusion) plus zPANSSP3 (hallucinations) + zPANNSP6 (suspiciousness) plus z score of item 11 of the BPRS (zBPRS11: suspiciousness) plus zBPRS12 (hallucinatory behavior) plus zBPRS15 (unusual thought content). Hostility sum of zPANSSP7 (hostility) plus z-score of item 14 on the general psychopathology scale of the PANSS (zPANSSG14: poor impulse control) plus zBPRS10 (hostility) plus zBPRS14 (uncooperativeness). Excitement zPANNSP4 (excitement) plus zPANNSP5 (grandiosity) plus zBPRS8 (grandiosity) plus zBPRS17 (excitement). Mannerism zPANNSG5 plus zBPRS7 (both mannerism and posturing) Formal thought disorders zPANNSP2 (conceptual disorganization) plus item 5 of the PANNS negative subscale (PANNSN5: difficulty in abstract thinking) plus zBPRS4 (item 4 of the BPRS or conceptual disorganization) Psychomotor retardation z-score of HDRS item 8 (HDRS8: psychomotor retardation: slowness of thought and speech, decreased motor activity, impaired inability to concentrate) plus zPANSSG7 (reduction in motor activity as reflected in slowing or lessening of movements and speech, diminished responsiveness to stimuli and reduced body tone) plus zBPRS13 (reduction in energy level evidenced in slowed movements).
SANS
Total sum on all items of the SANS PANSSnegative Sum of all items of the PANSS negative subscale PANNS: Positive and Negative Syndrome Scale; BPRS: Brief Psychiatric Rating Scale (BPRS); HDRS: Hamilton Depression Rating Scale SANS: Scale for the Assessment of Negative Symptoms The correlation coefficients were adjusted for age, sex, education.
All significant at p<0.001 Table 4 . Results of multiple regression analyses with negative or positive symptoms as dependent variables. 
Dependent
